Eyenovia Inc. Partners with Kinetiq to Launch Hyperliquid Validator for Institutional Staking

Reuters
28 Jun
<a href="https://laohu8.com/S/EYEN">Eyenovia Inc.</a> Partners with Kinetiq to Launch Hyperliquid Validator for Institutional Staking

Eyenovia Inc., a leader in ophthalmic technologies, has announced a new partnership with Kinetiq, a prominent liquid staking protocol. The collaboration has resulted in the creation of the co-branded "Kinetiq x Hyperion" validator, which provides a premier liquid staking solution for institutional HYPE token holders within the Hyperliquid ecosystem. This strategic initiative marks Eyenovia's active engagement with ecosystem projects, leveraging its recent acquisition of over one million HYPE tokens to enhance network stability and security. Supported by Pier Two's advanced infrastructure, the partnership aims to foster secure and integrated liquid staking on Hyperliquid, positioning Eyenovia as a unique bridge between public markets and the onchain economy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eyenovia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-063687), on June 27, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10